TABLE 1.

Analysis of cell morphological changes in different treatment groups^a

Group	Thin cell walls	Asymmetry of bacterial division	Distortion of septa	Total number of cells	Percentage of defective cells (thin cell walls) (%)	Percentage of defective cells (asymmetry of bacterial division) (%)	Percentage of defective cells (distortion of septa) (%)
WT	15	6	5	64	23.4	9.38	10.9
Ceftaroline fosamil	64	41	31	89	71.9 C	46.1 C	34.8 B
WYBQ-4	59	38	27	93	63.4 c	40.9 b	29.0 a

^aUppercase B represents a significant difference between the ceftaroline fosamil and WT groups (P < 0.01). Uppercase C represents an extremely significant difference between the ceftaroline fosamil and WT groups (P < 0.001). Lowercase a represents a significant difference between the WYBQ-4 and WT groups (P < 0.05). Lowercase b represents a significant difference between the WYBQ-4 and WT groups (P < 0.01). Lowercase c represents a significant difference between the WYBQ-4 and WT groups (P < 0.001).